Search results
3 lut 2021 · The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca is safe and effective at preventing COVID-19, with no severe cases and no hospitalisations, more than 22 days after the first dose. Results demonstrated vaccine efficacy of 76% ...
29 wrz 2021 · This trial of AZD1222 was designed to include diverse groups at high risk for exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and populations at increased risk...
30 gru 2020 · The Oxford-AstraZeneca vaccine has been approved for use in the UK, with the first doses due to be given on Monday. There will be 530,000 doses available from next week, and vaccination centres...
30 gru 2020 · The Oxford-AstraZeneca vaccine has been approved for use in the UK, with the first doses due to be given on Monday. There will be 530,000 doses available from next week, and vaccination...
8 mar 2022 · From the development of the CEPI-supported Oxford/AstraZeneca vaccine – which is used in more countries than any other – to the ground-breaking Recovery trial to evaluate life-saving treatments like dexamethasone, British science has played a leading role in protecting the world from COVID-19.
30 gru 2020 · The UK Medicines and Healthcare products Regulatory Agency (MHRA) has provided authorisation for emergency supply of COVID-19 Vaccine AstraZeneca, formerly AZD1222, for the active immunisation of individuals 18 years or older.
7 maj 2021 · Analysis of post-marketing surveillance data in the UK demonstrates that vaccination is highly effective and substantially reduces the risk of infection and severe COVID-19 disease and...
